Original Research
Published on 20 Sep 2022
Engineered cord blood megakaryocytes evade killing by allogeneic T-cells for refractory thrombocytopenia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.1018047
- 6,162 views
- 2 citations



